Investing.com - LianBio ADR (NASDAQ: LIAN) reported second quarter EPS of $-0.20, $0.09 better than the analyst estimate of $-0.29. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
LianBio ADR's stock price closed at $1.88. It is down -34.04% in the last 3 months and down -37.12% in the last 12 months.
LianBio ADR saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See LianBio ADR's stock price’s past reactions to earnings here.
According to InvestingPro, LianBio ADR's Financial Health score is "good performance".
Check out LianBio ADR's recent earnings performance, and LianBio ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar